Ruijing Bio

Shanghai, China · Founded 2017 · Privately Held (backing)

Developer of molecular diagnosis technology designed for precision cancer medicine. Ruijing Bio is based in Shanghai, China and was founded in 2017. Its last reported valuation was $109 million in Apr 2022. It has raised $44 million.

Last reported valuation

$109.1M

Oct 2026

Priced at

—

Total raised

$44.0M

Last round

—

How much has Ruijing Bio raised?

$44.0Macross 0 recorded rounds

Free account

More of Ruijing Bio with a free account

·Watch Ruijing Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Ruijing Bio investors

7 investors are on record for Ruijing Bio, including ZhenFund, Guotai Junan Innovation Investment, Shenzhen Yifeng Investment Management Enterprise and Prosperico Ventures.

For fundraisers

Raising for a company like Ruijing Bio?

7 investors have backed Ruijing Bio.

See all 7 investors →

Frequently asked about Ruijing Bio

How much has Ruijing Bio raised?: Ruijing Bio has raised $44.0M in total across 0 recorded funding rounds.